SK Hynix Reaches TrillionDollar Market Cap Milestone Amid AIDriven East Asian Stock Rally OpenAI IPO Filing Possible This Week Sources Say Offshore Betting Ads Top Violations List Says ASCI Realty Personal Care Also Flagged China Urges APEC Cooperation as Commerce Minister Skips Meeting Over Urgent Official Business White House Security Incident Secret Service Shoots Suspect Bystander Critically Injured Potential Market Impacts Aluminum Prices Surge Amid Iran Conflict US Companies Grapple with Rising Costs MPLX Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Wipro Q1 2026 Earnings EPS Misses Estimates Amid Challenging Demand Environment ADGM Q1 2026 Earnings EPS Misses Estimates Revenue Not Reported QMCO Q1 2026 Earnings EPS Beat Amidst Revenue Uncertainty as Stock Declines RDVT Q1 2026 Earnings EPS Beats Estimates by 4093 Stock Rises 217 Bloom Energy Q1 2026 Earnings EPS Soars Past Estimates Yet Stock Retreats SEALSQ Corp LAES Bounces Back Price Jumps 336 Amid Renewed Buying Interest Trevi Therapeutics TRVI Holds Near Resistance After Modest Gain Apollomics Inc APLM Holds Steady Near Support Level as Consolidation Persists Devon Energy Holds Steady Near 47 as Traders Weigh Support and Resistance Levels XCHG Limited XCH Rebounds From Key Support Resistance Test Ahead WWEs Saturday Nights Main Event 2026 Preview Potential Content Catalyst for TKO Group Holdings RideNow Group Inc RDNW Q1 2026 Earnings SmallerThanExpected Loss Provides Modest Relief Transdigm Group TDG Edges Higher as Aerospace Demand Supports Momentum Accuray Incorporated ARAY Q1 2026 Earnings Significant EPS Miss Triggers Volatile Stock Reaction MWA Q1 2026 Earnings EPS Beats Estimates by 647 Stock Declines Slightly REFR Q1 2026 Earnings Losses Continue with No Reported Revenue Stock Declines 066 AVX Q1 2026 Earnings Narrow Loss Reported Amid Limited Financial Disclosure CVNA Q1 2026 Earnings EPS Surprises to the Upside Stock Rallies PRGS Q1 2026 Earnings EPS Slightly Beats Estimates Stock Rises Purple Biotech Ltd PPBT Q1 2025 Earnings PreRevenue Biotech Reports Narrower Loss as Clinical Progress Continues